Is GitLab (GTLB) Now Offering A Rare Opportunity After Steep Share Price Slide?

  • If you are wondering whether GitLab's share price now reflects a fair deal or an overreaction, you are not alone. That is exactly what this article will unpack.
  • GitLab's stock has been under pressure recently, with a 10.1% decline over the last week, a 27.7% decline over the last month, a 36.9% decline year to date, and a 54.3% decline over the past year.
  • These moves have kept GitLab on many investors' watchlists, as the company remains a key name in DevOps and cloud based software development tools. The recent price performance sets the context for reassessing what the market is currently willing to pay for its growth story and competitive position.
  • On Simply Wall St's valuation checks, GitLab scores a 4 out of 6 for being undervalued. This suggests some measures flag potential value while others are more cautious, and we will walk through those methods before finishing with a more holistic way to think about what the stock might be worth to you.

Find out why GitLab's -54.3% return over the last year is lagging behind its peers.

Advertisement

Approach 1: GitLab Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a company might be worth by projecting its future cash flows and then discounting those back to today in dollar terms.

For GitLab, the model used is a 2 Stage Free Cash Flow to Equity approach. The company’s last twelve months free cash flow is about $222.9 million. Analysts provide forecasts for the next few years, and Simply Wall St then extends those projections further out. By 2031, free cash flow is projected at $515.05 million, with intermediate annual projections between 2026 and 2035 ranging from about $208.5 million to $709.97 million before discounting.

When all those projected cash flows are discounted back and summed, the DCF model arrives at an estimated intrinsic value of $54.06 per share. Compared with the current share price, this implies an intrinsic discount of 57.8%, which indicates that GitLab appears undervalued on this cash flow view.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests GitLab is undervalued by 57.8%. Track this in your watchlist or portfolio, or discover 47 more high quality undervalued stocks.

GTLB Discounted Cash Flow as at Mar 2026
GTLB Discounted Cash Flow as at Mar 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for GitLab.

Approach 2: GitLab Price vs Sales

For a company like GitLab that is still focused on scaling and reinvestment, revenue is often more informative than current earnings, so the P/S ratio tends to be a useful yardstick for comparing what investors are paying for each dollar of sales.

In general, higher expected growth and lower perceived risk can justify a higher P/S multiple. Slower growth or higher risk usually call for a lower and more conservative multiple. That context helps frame what qualifies as a “normal” or “fair” sales multiple for a given business.

GitLab currently trades on a P/S ratio of 4.06x. This sits above the Software industry average of 3.37x, but below the peer group average of 5.13x. Simply Wall St’s “Fair Ratio” for GitLab is 5.53x, which is the P/S multiple its model suggests based on factors such as earnings growth outlook, industry, profit margins, market cap and company specific risks.

The Fair Ratio aims to be more tailored than a simple peer or industry comparison because it adjusts for those fundamentals rather than assuming all software names deserve the same multiple. Comparing GitLab’s actual P/S of 4.06x with the Fair Ratio of 5.53x points to the shares trading at a discount on this metric.

Result: UNDERVALUED

NasdaqGS:GTLB P/S Ratio as at Mar 2026
NasdaqGS:GTLB P/S Ratio as at Mar 2026

P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your GitLab Narrative

Earlier we mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St let you attach your own story about GitLab to the numbers by linking your view on its future revenue, earnings and margins to a forecast and fair value, then comparing that to the current price. The tool updates automatically when fresh news or earnings arrive. You can see how different investors land in very different places, from a Community Narrative that values GitLab at US$34.00 per share to another that sees fair value closer to US$150.00. This gives you a clear, easy framework to decide whether the price on screen lines up with your own expectations.

Do you think there's more to the story for GitLab? Head over to our Community to see what others are saying!

NasdaqGS:GTLB 1-Year Stock Price Chart
NasdaqGS:GTLB 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:GTLB

GitLab

Develops software for the software development lifecycle in the United States, Europe, and the Asia Pacific.

Flawless balance sheet and good value.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1158.7% undervalued
32 users have followed this narrative
2 users have commented on this narrative
6 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.6% undervalued
49 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9220.2% undervalued
14 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$1908.3% undervalued
11 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

AV
IOT logo
Averagemike on Samsara ·

Samsara's Future PE Will Soar to 337.7x and the Future is Bright

Fair Value:US$57.34k99.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
JO
John_Eric
NOW logo
John_Eric on ServiceNow ·

The Company Nobody Brags About

Fair Value:US$266.0164.1% undervalued
30 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
AnimalDoctorKwon
A176750 logo
AnimalDoctorKwon on DuChemBIOLtd ·

DuChemBio absorbs Radio DNS Labs as Novartis injects 140B KRW into Korean RLT. With 100%+ OCF/EBITDA, the 6-mo lag is a de-risked steal.

Fair Value:₩10k43.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75029.1% undervalued
101 users have followed this narrative
1 users have commented on this narrative
9 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6514.6% undervalued
69 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative
BL
BlackGoat
CBRS logo
BlackGoat on Cerebras Systems ·

The Wafer Giant Threatening NVIDIA's GPU Hegemony

Fair Value:US$415.5449.5% undervalued
64 users have followed this narrative
3 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

ST
StoxEurope
AD logo
StoxEurope on Koninklijke Ahold Delhaize ·

I ran Ahold Delhaize through a three-model triangulation — DCF, dividend discount, and residual income — with every assumption published and tagged as fact or assumption. The interesting result isn't a number, it's a disagreement: the point estimates run from €20,03 (RIM) through €27,64 (DDM) to €64,91 (DCF), and the pairwise overlaps form two disjoint segments — €20,36–€21,54 and €39,60–€44,56. Between €21,54 and €39,60, no two of the three models agree. [img]https://staticm.fastcomments.com/1784197249786-1000x1000-ad-range-strip.png[/img] Most of the spread is lens properties rather than company drama. A dividend model structurally can't see the roughly half of shareholder returns Ahold pays through buybacks. The book is ~96 % goodwill from the 2016 merger, which pins the residual-income reading low. And ~83 % of the DCF's value sits beyond the explicit five years, so it leans hard on the terminal assumptions. Three honest lenses, three honest answers — the disagreement is the information. Disclosures Position disclosure: The author holds no position in Ahold Delhaize as at 9 July 2026. This valuation is a StoxEurope opinion, based on honest research. Mistakes are possible. This is not investment advice. Do your own research. This article demonstrates a valuation methodology. It is not an investment recommendation, is not personalised to any reader's circumstances, and every figure in it depends entirely on the stated assumptions

1
|
0